Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm
09:27am, Tuesday, 18'th Feb 2025
LOS ANGELES , Feb. 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company")
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK Lawsuit - GSK
07:25am, Tuesday, 18'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK CITY, NY / ACCESS Newswire / February 18, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GS
GSK plc Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK
05:45am, Tuesday, 18'th Feb 2025
NEW YORK , Feb. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit s
GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'
02:21am, Tuesday, 18'th Feb 2025
GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the fou
Shareholders that lost money on GSK plc(GSK) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
09:30pm, Monday, 17'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Rosen Law Firm PA WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (N
NEW YORK--(BUSINESS WIRE)---- $GSK #ClassAction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been fil
Investors in GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK
01:00pm, Monday, 17'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
11:30am, Monday, 17'th Feb 2025
Ken Griffin 's hedge fund Citadel has placed a £305 million ($390 million) short bet against GSK PLC GSK, marking the largest wager against the UK pharma giant in over a decade, reported the Financia
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against GSK plc
11:00am, Monday, 17'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 17, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the C
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK
07:25am, Monday, 17'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
PENMENVY, GSK's 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY
07:00am, Monday, 17'th Feb 2025
PHILADELPHIA--(BUSINESS WIRE)-- #Adolescents--PENMENVY, GSK's 5-in-1 meningococcal vaccine, approved by US FDA to help protect against MenABCWY.
NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GS
